Filing Flows › Healthpeak Properties (DOC) › Guidance & outlook
Healthpeak Properties (DOC) guidance and outlook
Healthpeak Properties (DOC) raised its guidance on Nov 2, 2026: EPS $0.48–$0.52 for FY2026; FFO per share $1.73–$1.77 for FY2026. Healthpeak Properties' 10-Q filed Nov 3, 2026 makes 20 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EPS | FY2026 | $0.48–$0.52 | raised |
| FFO per share | FY2026 | $1.73–$1.77 | raised |
From the earnings release filed Nov 2, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 3, 2026
- • our property development, redevelopment, and tenant improvement risks, which can render a project less profitable or unprofitable and delay or prevent its undertaking or completion;
- • cash available for distribution to stockholders and our ability to make dividend distributions at expected levels;
- We will discuss and provide our analysis in the following order:
- Our operating results have been and will continue to be impacted by global and national economic and market conditions generally and by the local economic conditions where our properties are located.
- We have also been affected by increased costs relating to tenant improvements and construction, which, together with higher costs of capital and tariff actions (or potential tariff actions), have adversely affected, and in the future may adversely affect, construction starts and the expected yields on our capital projects, including our developments and redevelopments.
- Under the terms of the agreement, we will maintain day-to-day control and management of the assets and will retain a call right for a finite period beginning after year seven to repurchase Brookfield’s interest at a price sufficient to provide Brookfield with a 6.5% net annual rate of return excluding initial transaction expenses.
- Our pro rata share information is prepared on a basis consistent with the comparable consolidated amounts, is intended to reflect our proportionate economic interest in the operating results of properties in our portfolio and is calculated by applying our economic share for the period.
- We use FFO as Adjusted to: (i) evaluate our performance in comparison with expected results and results of previous periods, relative to resource allocation decisions, (ii) evaluate the performance of our management, (iii) budget and forecast future results to assist in the allocation of resources, (iv) assess our performance as compared with similar real estate companies and the industry in general, and (v)…
- • an increase in Adjusted NOI generated from our lab segment related to: (i) acquisitions of real estate in 2025 and 2026, (ii) development and redevelopment projects placed in service during 2025 and 2026, and (iii) new leasing activity during 2025 and 2026 (including the impact to straight-line rents); partially offset by: (i) dispositions of real estate in 2026, (ii) assets placed into development and…
- • a decrease in Adjusted NOI generated from our outpatient medical segment related to: (i) dispositions of real estate in 2026 and 2025, (ii) assets placed into development and redevelopment in 2025 and 2026, and (iii) lower occupancy, partially offset by: (i) development and redevelopment projects placed in service during 2025 and 2026 and (ii) new leasing activity during 2025 and 2026 (including the impact to…
- • a decrease in Adjusted NOI generated from our outpatient medical and lab segments related to: (i) dispositions of real estate in 2026 and 2025, (ii) assets placed into development and redevelopment in 2025 and 2026, and (iii) lower occupancy, partially offset by: (i) acquisitions of real estate in 2025 and 2026, (ii) development and redevelopment projects placed in service during 2025 and 2026, and (iii) new…
- We anticipate that our cash flows from operations, available cash balances, and cash from our various financing activities will be adequate for the next 12 months and for the foreseeable future for purposes of: (i) funding recurring operating expenses; (ii) meeting debt service requirements; and (iii) satisfying funding of distributions to our stockholders and noncontrolling interest members.
Healthpeak Properties' latest quarter
Healthpeak Properties, Q3 2026: revenue $821M (+16% year over year), operating margin 3.1%, net earnings $17.3M, operating cash flow $354M. The chart follows the revenue to costs, profit and cash.
Questions
Did Healthpeak Properties raise or lower its guidance?
Healthpeak Properties (DOC) raised its guidance on Nov 2, 2026: EPS $0.48–$0.52 for FY2026; FFO per share $1.73–$1.77 for FY2026.
What does Healthpeak Properties expect?
• our property development, redevelopment, and tenant improvement risks, which can render a project less profitable or unprofitable and delay or prevent its undertaking or completion; • cash available for distribution to stockholders and our ability to make dividend distributions at expected levels; We will discuss and provide our analysis in the following order:
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.